Startseite
Podcasts
BiocompCHATibility Podcast
Navigating Biocompatibility in Early Feasibility Studies

Navigating Biocompatibility in Early Feasibility Studies

BiocompCHATibility vor 2 Jahren

0:00

22:38

Podcast

BiocompCHATibility

38 Episoden

A podcast dedicated to medical device biocompatibility

Wissenschaft Gesundheit & Fitness

Podcast aneignen

In this episode of NAMSA’s BiocompCHATibility Podcast, our hosts
discuss early feasibility studies and the scope of
biocompatibility necessary to get started. They highlight the
importance of controlling device response in a small patient
group and how this approach shapes biocompatibility
considerations within the framework of risk management.

“The control measure of just having a few patients is definitely
used as a reason why, in part Biocompatibility doesn't need to be
as extensive as it needs to be for a pivotal where you have
hundreds of people and commercialization where you lose
practically all control.” – Don Pohl

“I want to make sure I'm choosing materials that I can support in
my plan that I know have a general knowledge of safety.” – Sheri
Krajewski

“There's no specific guidance that tells you what you
have to do in terms of testing and what you don't, but
the concept is you're going to creep up on everything
you'll do. You'll do some biocomp for early feasibility.” – Don
Pohl

Key Discussion Points:

Crafting a dynamic biological safety plan that evolves over
time

Establishing a robust evaluation strategy from the beginning
to prevent missing important tests later

Designing studies for high-risk cardiovascular implants and
the importance of addressing biocompatibility and safety concerns